Health Condition 1: L80- Vitiligo
Conditions
Interventions
Intervention1: SAFUF BARA?
: SAFUF BARA? (Containing Post-i-Katomari,Pos-i-Nim,Ch ?ksu,Tukhm Panw ?r and B ?bchi) will be used both internally as a Zul ?l (Decanted water) and externally as a Sufl (Se
Sponsors
NATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS
Eligibility
Inclusion criteria
Inclusion criteria: The following patients will be included in the study: 1.Patients of any sex aged 18-60 years 2.Non-Segmental Vitiligo with Chronicity of 6 months to 2 years 3.Vitiligo involving more than 2% Body Surface Area (BSA) 4.Patients with less than 5 New Lesions in the last month 5.Patients with less than 15 lesions in the last 3 months 6.Patients who have not received systemic treatment within 4 weeks prior to study entry 7.Patients who have not received topical treatment within 2 weeks prior to study entry
Exclusion criteria
Exclusion criteria: The following patients will be excluded: 1.Patients aged less than 18 years or more than 60 years 2. Segmental Vitiligo/ Lip-Tip Vitiligo/ Universal Vitiligo/ Vitiligo with Leucotrichia 3. Significant Pulmonary/ Cardiovascular/ Hepatorenal Dysfunction, and other Disorders requiring long-term treatment 4. Known cases of Immunocompromised states (HIV/ AIDS, etc.)/ Malignancies 5. Pregnant or Lactating Women Patient not willing to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Vitiligo Area Scoring Index (VASI) Timepoint: 0,2,4 and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Vitiligo Impact Scale-22 (VIS- (Assessment of Patient’s Quality of Life) 2. Improvement in Patient’s Global Assessment (PGA) on VAS 3. Improvement in Investigators Global Assessment (IGA)Timepoint: 0 and 8 weeks | — |
Countries
India
Contacts
Public ContactDR MOHD TARIQUE
Outcome results
None listed